Abstract
In an oncology setting, technetium-99m methylene diphosphonate (Tc-99m MDP) bone scans are done to assist in the diagnosis of bone metastases. Extra-skeletal Tc -99m MDP uptake is occasionally seen and is usually due to an artifact or a flaw in the procedure [1]. True extra-skeletal findings are unusual and relate mainly to the excretion of radio active tracer via the urinary system [1, 2]. Here, we present such a case of an unexpected finding of liver metastases in a patient who had a bone scan as part of her investigation into the cause of her hypercalcaemia. A brief review of the literature accompanies this report.
Current Radiopharmaceuticals
Title: An Unexpected Diagnosis of Liver Metastases on a Bone Scan
Volume: 2 Issue: 3
Author(s): Sangeetha Poovaneswaran and Philip J. Atherton
Affiliation:
Abstract: In an oncology setting, technetium-99m methylene diphosphonate (Tc-99m MDP) bone scans are done to assist in the diagnosis of bone metastases. Extra-skeletal Tc -99m MDP uptake is occasionally seen and is usually due to an artifact or a flaw in the procedure [1]. True extra-skeletal findings are unusual and relate mainly to the excretion of radio active tracer via the urinary system [1, 2]. Here, we present such a case of an unexpected finding of liver metastases in a patient who had a bone scan as part of her investigation into the cause of her hypercalcaemia. A brief review of the literature accompanies this report.
Export Options
About this article
Cite this article as:
Poovaneswaran Sangeetha and Atherton J. Philip, An Unexpected Diagnosis of Liver Metastases on a Bone Scan, Current Radiopharmaceuticals 2009; 2 (3) . https://dx.doi.org/10.2174/1874471010902030220
DOI https://dx.doi.org/10.2174/1874471010902030220 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis
Current Drug Targets Interactions of Metal Ions with DNA, Its Constituents and Derivatives, which may be Relevant for Anticancer Research
Current Topics in Medicinal Chemistry Quercetin in Cancer Treatment, Alone or in Combination with Conventional Therapeutics?
Current Medicinal Chemistry Clinical Development of mTOR Inhibitors: A Focus on Lymphoma
Reviews on Recent Clinical Trials The Hydroxamic Acids as Potential Anticancer and Neuroprotective Agents
Current Medicinal Chemistry Nitric Oxide Control of Proliferation in Nerve Cells and in Tumor Cells of Nervous Origin
Current Pharmaceutical Design 3-Substituted Isocoumarins as Thymidine Phosphorylase Inhibitors
Letters in Drug Design & Discovery The Retinoblastoma Protein in Osteoblast Differentiation and Osteosarcoma
Current Molecular Medicine Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated with Varicose Veins
Current Drug Targets Recent Developments in the Regulation of Monoamine Oxidase Form and Function: Is the Current Model Restricting Our Understanding of the Breadth of Contribution of Monoamine Oxidase to Brain [dys]Function?
Current Topics in Medicinal Chemistry Targeting the Type I Insulin-Like Growth Factor System for Breast Cancer Therapy
Current Drug Targets Structure and Design of Polycationic Carriers For Gene Delivery
Mini-Reviews in Medicinal Chemistry Low Dose Aspirin, COX-Inhibition and Chemoprevention of Colorectal Cancer
Current Topics in Medicinal Chemistry Current Bioactive Azole-Containing Natural Products
Current Bioactive Compounds Molecular Modelling and QSAR in the Discovery of HIV-1 Integrase Inhibitors
Current Computer-Aided Drug Design Attacking c-Myc: Targeted and Combined Therapies for Cancer
Current Pharmaceutical Design VEGF in Tumor Progression and Targeted Therapy
Current Cancer Drug Targets Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells
Current Cancer Drug Targets Suppression of Inflammatory and Allergic Responses by Pharmacologically Potent Fungus Ganoderma lucidum
Recent Patents on Inflammation & Allergy Drug Discovery Lymphatics and Inflammation
Current Medicinal Chemistry